Company profilePharmaceutical#26 of 1,318 in Pakistan✓ No DRAP alerts

HIGHNOON LABORATORIES LIMITED

Pharmaceutical company · 325 brands · 312 molecules

Ranked #5 of 70 companies in Cardiac Care

325 registered products 88 pharmaceutical brands 312 distinct molecules 0 DRAP alerts

Company overview

325
registered products
88
pharmaceutical brands
312
distinct molecules
12
therapeutic classes
0
DRAP alerts

HIGHNOON LABORATORIES LIMITED is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 325 product registrations across 312 distinct molecules. It is the 26th largest registrant in Pakistan by product count, and ranks 5th of 70 in Cardiac Care. Its portfolio is concentrated in Cardiac Care and Drugs For Obstructive Airway Diseases, Inhalants. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Reported financials

PSX-listed · fiscal year 2024 (Dec 31, 2024)

24.63B PKR
revenue
3.39B PKR
net profit
63.95 PKR
EPS

24.6% revenue growth, 38.4% profit surge. Top therapeutic areas: cardiology, metabolic, gastroenterology.

Source: company filing

Products by HIGHNOON

370 products matched in our catalogue · showing 80 — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

178
ceilings with an approval date
3
not revised in 2+ years
2024
oldest approval year
20243
202515
2026160
Longest without revision

Top molecules by brand count

Artemether11 brands
Formoterol10 brands
Budesonide10 brands
Telmisartan10 brands
Metformin9 brands
Ondansetron6 brands
Valsartan5 brands
Ribavirin5 brands

Therapeutic classes

Cardiac Care · 16Drugs For Obstructive Airway Diseases, Inhalants · 14Blood Glucose Lowering Drugs, Excluding Insulin · 13Anti-Infectives · 12Respiratory Care · 12Angiotensin-Ii Antagonists, Combinations · 9Other Beta-Lactam, Cephalosporins & Penems · 9Gastro · 9Antithrombotic Agents · 8Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 6Pain Management · 5Diabetes · 5

Conditions treated

Asthma/Copd · 11General Infections · 9Hypertension · 8Ulcer/Reflux/Flatulence/Acidity · 6Oral Agents · 5Heart Failure · 4Blood Clot/Thrombotic Disorder · 4Angina · 3Non-Sedative Agents · 3Pain Killers · 2Bladder & Prostate Disorder · 2Conventional Agents · 2

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official247 products · Rs 28.1 – Rs 42,161.44
DVAGO118 products · Rs 23.59 – Rs 1,900
Servaid164 products · Rs 41.06 – Rs 1,016.1
Median across source: Rs 328.17

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

GETZ PHARMA PAKISTAN (PVT) LTD. holds 186 molecules not in this portfolio
),Formoterol3 ) 20Mg} Folic AcidAcetazolamideAdrenalineAlbendazoleAmitriptyline
MACTER INTERNATIONAL (PVT) LTD. holds 118 molecules not in this portfolio
10Ug Polysaccharides Covalently Bound To 20Ug To 32Ug Of Tetanus ToxoidAlbendazoleAlbuterolAlfacalcidolAluminium HydroxideAluminium Hydroxide And Oxide
Atco Pharma International (Pvt) Ltd holds 180 molecules not in this portfolio
Acetylsalicylic AcidAdapaleneAdapleneAlbuterolAminophyllineAmlodipine 6.95Mg Amlodipine Base

Get the full profile for HIGHNOON

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.